Drug Alert: Co-Codamol  Tablets

The Medical Medicines and Healthcare products Regulatory Agency (MHRA) has issued on Friday 23rd March, a contaminated drugs alert as follows:

Wockhardt UK Ltd

Co-codamol 8/500 tablets (codeine phosphate 8mg, paracetamol 500mg)
containing rogue Co-codamol 30/500 tablets

PL 29831/0045

Batch number	Expiry date	Pack size	First distributed
LL11701	September 2014	32 tablets	30 December 2011

We have received reports of rogue higher-strength Co-codamol 30/500 tablets found in blisters of one batch of the lower strength 8/500 tablets. The defect has been confirmed by analytical testing and examination carried out by Wockhardt UK Ltd.

The different strengths are marked as follows. The 8mg/500mg tablets are marked on one-side only as “<AB>” and are unmarked on the second side.  The rogue higher strength tablets are marked on one side as “CCD30” and marked as “CP” on the second side.

Recipients are requested to contact patients wherever possible and ask them to return any remaining stock of batch LL11701 Co-codamol 8/500 tablets to the pharmacy where they were dispensed.

The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe. The MHRA is an executive agency of the Department of Health.

You can see the original warning on their website here

Source:MHRA

Designed, Hosted and Maintained by Union Safety Services